Role of 18F-FDG PET/CT in the detection of ovarian cancer recurrence in the setting of normal tumor markers

Role of 18F-FDG PET/CT in the detection of ovarian cancer recurrence in the setting of normal tumor markers

Purpose: To evaluate the diagnostic performance of 18F-flurodeoxyglucose positron emission tomography/contrast enhanced computed tomography (18F-FDG PET/CT) in patients with clinically/radiologically suspected ovarian tumor recurrence and normal tumor markers. Materials and methods: A total of 54 18...

Full description

Bibliographic Details
Main Authors:	Yasser Abdelhafez, Ahmed Tawakol, Amr Osama, Emad Hamada, Sherif El-Refaei
Format:	Article
Language:	English
Published:	SpringerOpen 2016-12-01
Series:	The Egyptian Journal of Radiology and Nuclear Medicine
Subjects:	FDG PET/CT Contrast enhanced CT Ovarian cancers Normal tumor markers
Online Access:	http://www.sciencedirect.com/science/article/pii/S0378603X16301589

Similar Items

Role of 18F FDG PET/CT in evaluation of post-operative ovarian carcinoma
by: Marwa Ibrahim El-Sayed Amer, et al.
Published: (2022-09-01)

To Enhance or Not to Enhance? The Role of Contrast Medium <sup>18</sup>F-FDG PET/CT in Recurrent Ovarian Carcinomas
by: Michela Massollo, et al.
Published: (2021-06-01)

The predominant role of 18F-FDG PET/CT over MDCT in assessment of ovarian cancer patient
by: Hemat A. Mahmoud, et al.
Published: (2015-12-01)

Diagnostic value of [18F]FDG PET/MRI for staging in patients with ovarian cancer
by: Hideaki Tsuyoshi, et al.
Published: (2020-10-01)

Value of contrast CT in combination with PET/CT in mesothelioma staging: Optimal protocol for initial assessment
by: Mohamed Houseni, et al.
Published: (2017-03-01)

Pretherapeutic Assessment of Pancreatic Cancer: Comparison of FDG PET/CT Plus Delayed PET/MR and Contrast-Enhanced CT/MR
by: Zaizhu Zhang, et al.
Published: (2022-01-01)

The role of 18F-FDG PET/CT in the management of large-vessel vasculitis: applications and limitations in clinical practice
by: Maria V. Mattoli, et al.
Published: (2012-01-01)

18F-FDG PET/MRI and 18F-FDG PET/CT for the Management of Gynecological Malignancies: A Comprehensive Review of the Literature
by: Leila Allahqoli, et al.
Published: (2023-10-01)

Impact of Renal Failure on F18-FDG PET/CT Scans
by: Vishwajit Kode, et al.
Published: (2017-07-01)

The role of 18F-FDG-PET/CT in the preoperative staging and posttherapy follow up of gastriccancer:Comparison with spiral CT
by: Soydal Cigdem, et al.
Published: (2011-07-01)

Imaging Features of Multiple Myeloma Extramedullary Lesions in the Liver with 18F-FDG PET/CT, Contrast-Enhanced CT and MRI
by: Dimitris Papamichail, et al.
Published: (2019-11-01)

Added value of 18-F-FDG-PET/CT in patients with pancreatic cancer: Initial observation
by: Ekhlas Abdelmonem Ibrahem Nasr Shaban
Published: (2016-12-01)

Value of 18-F-FDG PET/CT in assessment of patients with fever of unknown origin
by: Sherif Fathy Abdelrahman, et al.
Published: (2018-06-01)

The role of 18F-FDG PET/CT in evaluation of Primary CNS lymphoma: The path less travelled
by: Sharjeel Usmani, et al.
Published: (2023-07-01)

The accuracy of whole-body 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) in the detection of ovarian cancer relapse in patients with rising cancer antigen 125 (CA-125) levels
by: Soha Sami, et al.
Published: (2023-09-01)

Diagnosis of an intestinal mucormycosis ‘fungus ball’ located with PET/CT with [18F] FDG-PET/CT
by: Franklin Gallo, et al.
Published: (2019-12-01)

Meta-analysis of the diagnostic value of 18F-FDG PET/CT in the recurrence of epithelial ovarian cancer
by: Xiaoyan Wang, et al.
Published: (2022-11-01)

The role of 18FDG PET/CT in evaluation of unknown primary tumors
by: Marković Bogdan, et al.
Published: (2019-01-01)

The place of <sup>18</sup>F FDG PET/CT in the management of patients with eosinophilic fasciitis: a case report
by: N. Belfeki, et al.
Published: (2021-01-01)

Non-FDG PET/CT in Diagnostic Oncology: a pictorial review
by: Francesco Giammarile, et al.
Published: (2019-11-01)

Immunohistophenotyping and 18F-FDG PET-CT in characterizing malignant breast tumors: preliminary results
by: A. Fathinul Fikri, et al.
Published: (2020-03-01)

Diagnostic utility of 68Ga-citrate and 18FDG PET/CT in sarcoidosis patients
by: Cuneyt Tetikkurt, et al.
Published: (2020-12-01)

18F‐FDG PET/CT imaging of several asymptomatic skeletal muscle metastases of mixed germ cell ovarian cancer
by: Maryam Abdinejad, et al.
Published: (2023-06-01)

Evaluation of Malignancy Risk in 18F-FDG PET/CT Thyroid Incidentalomas
by: Maria-Iulia Larg, et al.
Published: (2019-08-01)

18F-FDG PET/CT in pleural epithelioid hemangioendothelioma
by: Domenico Albano, et al.
Published: (2017-01-01)

Case report: Imaging findings of true thymic hyperplasia at 18F-FDG PET/CT in an infant
by: Jiazhong Ren, et al.
Published: (2023-01-01)

Scar sarcoidosis on 18F-FDG PET/CT
by: Saurabh Arora, et al.
Published: (2019-06-01)

Up and down staging of TCC using 18F-FDG PET/CT scan
by: Tamer W. Kassem
Published: (2016-09-01)

Clinical value of baseline 18F-FDG PET/CT in soft tissue sarcomas
by: Rafael Hernando Reyes Marlés, et al.
Published: (2021-09-01)

Extensive Metastatic Sarcomatoid Renal Cell Carcinoma Evaluated by 18F-FDG PET/CT: a Case Report and Review of Literature
by: Dominique Fuser, et al.
Published: (2018-01-01)

Diagnostic Value of <sup>18</sup>F-FDG-PET/CT in Patients with FUO
by: Stamata Georga, et al.
Published: (2020-07-01)

COVID-19 in an asymptomatic patient undergoing FDG PET/CT
by: Lisa N. Johnson, MD, et al.
Published: (2020-10-01)

18F-FDG PET/CT in Neurolymphomatosis: Report of 3 Cases
by: Nguyen Xuan Canh, et al.
Published: (2014-05-01)

Pitfalls and value of organ specific approach in evaluating indeterminate lesions detected on CT in colorectal cancer by [F18] FDG PET/CT
by: Wael M. Marashdeh, et al.
Published: (2020-01-01)

The Role of PET-CT in Gastric Cancer — A Narrative Review
by: Raluca-Ioana Dascălu, et al.
Published: (2020-09-01)

A Retrospective Analysis of the Most Common Bone Metastases of Various Malignant Tumors with Cross-sectional Imaging and 18-FDG-PET/CT Data
by: Mehmet Öncü, et al.
Published: (2022-03-01)

Application of FDG-PET/CT in Radiation Oncology
by: Jun eLi, et al.
Published: (2013-04-01)

The role of 18-FDG PET/CT assessment of functional brain metabolism in cancer patients after chemotherapy
by: Shady Mohamed Tarek Gamal, et al.
Published: (2021-01-01)

The ability of whole-body SUVmax in F-18 FDG PET/CT to predict suboptimal cytoreduction during primary debulking surgery for advanced ovarian cancer
by: Gun Oh. Chong, et al.
Published: (2019-02-01)

Evaluation of the efficiency of FDG PET/CT in detection and characterization of skeletal metastases
by: Ahmed Wafaie, et al.
Published: (2014-03-01)